Clinical Trials Browser

Phase 1 × Terminated × Clarithromycin × Clear all

NCT03043989 2020-02-17

Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin

Phase 1 Terminated

Prostatic Neoplasms